Neurosarcoidosis

Abstract

Sarcoidosis is an idiopathic multisystem granulomatous disorder. Neurologic manifestations in sarcoidosis are varied and making a diagnosis of neurosarcoidosis can be difficult as it mimics various other neurologic diseases. Knowledge of the syndromes associated with neurosarcoidosis can help guide the diagnostic evaluation. Definitive diagnosis requires neurologic tissue evidence of noncaseating granuloma, but in practice probable diagnosis is often made through nonneurologic biopsy and a characteristic syndrome and imaging. Treatment remains empiric, but new advances in immunologic therapy hold promise for effective and less-toxic regimens.

Keywords

sarcoidosis - neurologic complications - neurosarcoidosis - cranial neuropathy - aseptic meningitis - granuloma - myelitis

Note

Shruti P. Agnihotri and Tarun Singhal contributed equally to the article.

• References

• 1 Sharma OP. Sarcoidosis around the world. Clin Chest Med 2008; 29 (3) 357-363 vii vii
• 2 Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357 (21) 2153-2165
• 3 Rybicki BA, Major M, Popovich Jr J, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145 (3) 234-241
• 4 Krumholz A, Stern BJ. Neurologic manifestations of sarcoidosis. Handb Clin Neurol 2014; 119: 305-333
• 5 Baughman RP, Teirstein AS, Judson MA , et al; Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164 (10 Pt 1) 1885-1889
• 6 Rybicki BA, Iannuzzi MC, Frederick MM , et al; ACCESS Research Group. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001; 164 (11) 2085-2091
• 7 Gascón-Bayarri J, Mañá J, Martínez-Yélamos S, Murillo O, Reñé R, Rubio F. Neurosarcoidosis: report of 30 cases and a literature survey. Eur J Intern Med 2011; 22 (6) e125-e132
• 8 Allen RK, Sellars RE, Sandstrom PA. A prospective study of 32 patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20 (2) 118-125
• 9 Manz HJ. Pathobiology of neurosarcoidosis and clinicopathologic correlation. Can J Neurol Sci 1983; 10 (1) 50-55
• 10 Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol 1985; 42 (9) 909-917
• 11 Scott TF, Yandora K, Valeri A, Chieffe C, Schramke C. Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients. Arch Neurol 2007; 64 (5) 691-696
• 12 Chapelon C, Ziza JM, Piette JC , et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) 1990; 69 (5) 261-276
• 13 Newman LS, Rose CS, Bresnitz EA , et al; ACCESS Research Group. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004; 170 (12) 1324-1330
• 14 Nowak DA, Widenka DC. Neurosarcoidosis: a review of its intracranial manifestation. J Neurol 2001; 248 (5) 363-372
• 15 Wraith DC, Nicholson LB. The adaptive immune system in diseases of the central nervous system. J Clin Invest 2012; 122 (4) 1172-1179
• 16 Aszkanazy CL. Sarcoidosis of the central nervous system. J Neuropathol Exp Neurol 1952; 11 (4) 392-400
• 17 Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 1977; 87 (3) 336-345
• 18 Douglas AC, Maloney AF. Sarcoidosis of the central nervous system. J Neurol Neurosurg Psychiatry 1973; 36 (6) 1024-1033
• 19 Said G, Lacroix C, Planté-Bordeneuve V , et al. Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain 2002; 125 (Pt 2) 264-275
• 20 Hoitsma E, Faber CG, Drent M, Sharma OP. Neurosarcoidosis: a clinical dilemma. Lancet Neurol 2004; 3 (7) 397-407
• 21 Hewlett RH, Brownell B. Granulomatous myopathy: its relationship to sarcoidosis and polymyositis. J Neurol Neurosurg Psychiatry 1975; 38 (11) 1090-1099
• 22 Joseph FG, Scolding NJ. Neurosarcoidosis: a study of 30 new cases. J Neurol Neurosurg Psychiatry 2009; 80 (3) 297-304
• 23 Pawate S, Moses H, Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM 2009; 102 (7) 449-460
• 24 Zajicek JP, Scolding NJ, Foster O , et al. Central nervous system sarcoidosis—diagnosis and management. QJM 1999; 92 (2) 103-117
• 25 Smith JK, Matheus MG, Castillo M. Imaging manifestations of neurosarcoidosis. AJR Am J Roentgenol 2004; 182 (2) 289-295
• 26 Christoforidis GA, Spickler EM, Recio MV, Mehta BM. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. AJNR Am J Neuroradiol 1999; 20 (4) 655-669
• 27 James DG, Sharma OP. Neurosarcoidosis. Proc R Soc Med 1967; 60 (11 Part 1) 1169-1170
• 28 Lacomis D. Neurosarcoidosis. Curr Neuropharmacol 2011; 9 (3) 429-436
• 29 Hamada H, Hayashi N, Kurimoto M, Umemura K, Hirashima Y, Endo S. Isolated third and fourth ventricles associated with neurosarcoidosis successfully treated by neuroendoscopy—case report. Neurol Med Chir (Tokyo) 2004; 44 (8) 435-437
• 30 Langrand C, Bihan H, Raverot G , et al. Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients. QJM 2012; 105 (10) 981-995
• 31 Rubinstein I, Gray TA, Moldofsky H, Hoffstein V. Neurosarcoidosis associated with hypersomnolence treated with corticosteroids and brain irradiation. Chest 1988; 94 (1) 205-206
• 32 Sohn M, Culver DA, Judson MA, Scott TF, Tavee J, Nozaki K. Spinal cord neurosarcoidosis. Am J Med Sci 2014; 347 (3) 195-198
• 33 Stern BJ. Neurological complications of sarcoidosis. Curr Opin Neurol 2004; 17 (3) 311-316
• 34 James DG, Sharma OP. From Hutchinson to now: a historical glimpse. Curr Opin Pulm Med 2002; 8 (5) 416-423
• 35 Krumholz A, Stern BJ. Neurologic manifestations of sarcoidosis. In: Aminoff MJ, Boller F, Swaab DF, , eds. Handbook of Clinical Neurology. Amsterdam: Elsevier; 2014. 119. 305-333
• 36 Siva A. Vasculitis of the nervous system. J Neurol 2001; 248 (6) 451-468
• 37 Brown MM, Thompson AJ, Wedzicha JA, Swash M. Sarcoidosis presenting with stroke. Stroke 1989; 20 (3) 400-405
• 38 Hodge MH, Williams RL, Fukui MB. Neurosarcoidosis presenting as acute infarction on diffusion-weighted MR imaging: summary of radiologic findings. AJNR Am J Neuroradiol 2007; 28 (1) 84-86
• 39 Hohlfeld SK, Günthard HF, Zeitz J, Locher P, Bachli E. Progressive multi-focal leukoencephalopathy as a rare lethal complication in untreated sarcoidosis. BMJ Case Rep 2012; 2012
• 40 De Raedt S, Lacor P, Michotte A, Flamez A, Ebinger G. Progressive multifocal leukoencephalopathy as first manifestation of sarcoidosis. Clin Neurol Neurosurg 2008; 110 (2) 186-189
• 41 Cremers JP, Van Kroonenburgh MJ, Mostard RL , et al. Extent of disease activity assessed by 18F-FDG PET/CT in a Dutch sarcoidosis population. Sarcoidosis Vasc Diffuse Lung Dis 2014; 31 (1) 37-45
• 42 Khoury J, Wellik KE, Demaerschalk BM, Wingerchuk DM. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist 2009; 15 (2) 108-111
• 43 Scott TF, Yandora K, Kunschner LJ, Schramke C. Neurosarcoidosis mimicry of multiple sclerosis: clinical, laboratory, and imaging characteristics. Neurologist 2010; 16 (6) 386-389
• 44 Otake S. Sarcoidosis involving skeletal muscle: imaging findings and relative value of imaging procedures. AJR Am J Roentgenol 1994; 162 (2) 369-375
• 45 Hoitsma E, Marziniak M, Faber CG , et al. Small fibre neuropathy in sarcoidosis. Lancet 2002; 359 (9323) 2085-2086
• 46 Nozaki K, Scott TF, Sohn M, Judson MA. Isolated neurosarcoidosis: case series in 2 sarcoidosis centers. Neurologist 2012; 18 (6) 373-377
• 47 Pula JH, Macdonald CJ. Current options for the treatment of optic neuritis. Clin Ophthalmol 2012; 6: 1211-1223
• 48 Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997; 157 (16) 1864-1868
• 49 Androdias G, Maillet D, Marignier R , et al. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy. Neurology 2011; 76 (13) 1168-1172
• 50 Agbogu BN, Stern BJ, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995; 52 (9) 875-879
• 51 Sharma OP. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. Arch Neurol 1998; 55 (9) 1248-1254
• 52 Bomprezzi R, Pati S, Chansakul C, Vollmer T. A case of neurosarcoidosis successfully treated with rituximab. Neurology 2010; 75 (6) 568-570
• 53 Baughman RP, Drent M, Kavuru M , et al; Sarcoidosis Investigators. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 2006; 174 (7) 795-802
• 54 Pettersen JA, Zochodne DW, Bell RB, Martin L, Hill MD. Refractory neurosarcoidosis responding to infliximab. Neurology 2002; 59 (10) 1660-1661
• 55 O'Reilly MW, Sexton DJ, Dennedy MC , et al. Radiological remission and recovery of thirst appreciation after infliximab therapy in adipsic diabetes insipidus secondary to neurosarcoidosis. QJM 2013; (Feb) 14
• 56 Terushkin V, Stern BJ, Judson MA , et al. Neurosarcoidosis: presentations and management. Neurologist 2010; 16 (1) 2-15